S.Amdt. 3399

SA 3399. Ms. HEITKAMP submitted an amendment intended to be proposed
by her to the bill S. 524, to authorize the Attorney General to award
grants to address the national epidemics of prescription opioid abuse
and heroin use; which was ordered to lie on the table; as follows:

At the end of title VI, add the following:

SEC. 602. COORDINATION OF PRESCRIPTION DRUG MONITORING
PROGRAMS WITH THE INDIAN HEALTH SERVICE.

(a) Definition of Eligible Entity.--In this section, the
term ``eligible entity'' means--
(1) a State; or
(2) an Indian tribe (as defined in section 4 of the Indian
Self-Determination and Education Assistance Act (25 U.S.C.
450b)).
(b) Grants for Coordination Pilot Programs.--
(1) In general.--The Attorney General, subject to the
availability of appropriations, may award grants to eligible
entities under the Harold Rogers Prescription Drug Monitoring
Program established under the Departments of Commerce,
Justice, and State, the Judiciary, and Related Agencies
Appropriations Act, 2002 (Public Law 107-77; 115 Stat. 748)
to carry out a pilot program described in paragraph (2).
(2) Requirements.--An eligible entity awarded a grant under
paragraph (1) to carry out a pilot program shall coordinate
with 1 or more service units of the Indian Health Service in
the State or on the applicable Indian land and meaningfully
consult and engage in a timely manner with Indian tribes
served by the service units to improve the connection,
coordination, and interoperability of each applicable Indian
health program (as defined in section 4 of the Indian Health
Care Improvement Act (25 U.S.C. 1603)) with the prescription
drug monitoring program of the applicable State.
(c) GAO Study.--Not later than 1 year after the date of
enactment of this Act, the Comptroller General of the United
States shall study and submit to the Committee on Indian
Affairs of the Senate and the Committee on Natural Resources
of the House of Representatives a report identifying barriers
to, and potential solutions to improve, coordination
between--
(1) each applicable Indian health program (as defined in
section 4 of the Indian Health Care Improvement Act (25
U.S.C. 1603)); and
(2) prescription drug monitoring programs in the United
States.
______